Erythrodermic psoriasis associated with hyperuricemia and Iatrogenic Cushing's syndrome due to topical corticosteroid therapy.
Ohnishi
T
T
Suzuki
T
T
Watanabe
S
S
Takahashi
H
H
D000287:Administration, Topical; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D002990:Clobetasol / Q000009:adverse effects / Q000031:analogs & derivatives*; D003480:Cushing Syndrome / Q000139:chemically induced*; D003873:Dermatitis, Exfoliative / Q000150:complications* / Q000473:pathology; D005938:Glucocorticoids; D006801:Humans; D007049:Iatrogenic Disease; D008297:Male; D009824:Ointments; D011565:Psoriasis / Q000150:complications* / Q000473:pathology; D012651:Self Medication / Q000009:adverse effects; D014527:Uric Acid / Q000097:blood*
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D009824:Ointments; D014527:Uric Acid; D002990:Clobetasol